Related references
Note: Only part of the references are listed.Compliance with pregnancy prevention programmes of isotretinoin in Europe: a systematic review
H. J. M. J. Crijns et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Patterns of Antidepressant Medication Use Among Pregnant Women in a United States Population
Sura Alwan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
How Valid Are the Rates of Down Syndrome Internationally? Findings from the International Clearinghouse for Birth Defects Surveillance and Research
Emanuele Leoncini et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
The Nordic Countries as a Cohort for Pharmacoepidemiological Research
Kari Furu et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2010)
Use of psychotropic drugs before pregnancy and the risk for induced abortion: population-based register-data from Finland 1996-2006
Mika Gissler et al.
BMC PUBLIC HEALTH (2010)
EUROCAT website data on prenatal detection rates of congenital anomalies
Ester Garne et al.
JOURNAL OF MEDICAL SCREENING (2010)
Pharmacoepidemiological research using French reimbursement databases: yes we can!
Karin Martin-Latry et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Surveillance of adverse fetal effects of medications (SAFE-Med): Findings from the International Clearinghouse of Birth Defects Surveillance and Research
Alessandra Lisi et al.
REPRODUCTIVE TOXICOLOGY (2010)
Prescriptions filled during pregnancy for drugs with the potential of fetal harm
S. Kulaga et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2009)
Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database
I. Lacroix et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006
Anders Engeland et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Data resources for investigating drug exposure during pregnancy and associated outcomes - The General Practice Research Database (GPRD) as an alternative to pregnancy registries
Rachel A. Charlton et al.
DRUG SAFETY (2008)
Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study
Mette Norgaard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Maternal characteristics associated with pregnancy exposure to FDA category C, D, and X drugs in a Canadian population
Tubao Yang et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Using observational cohort data for studying drug effects on pregnancy outcome - Methodological considerations
Christof Schaefer et al.
REPRODUCTIVE TOXICOLOGY (2008)
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects
Carol Louik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations
Pia Wogelius et al.
EPIDEMIOLOGY (2006)
Prevalence and patterns of antidepressant drug use during pregnancy
Tessa Ververs et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Lethal congenital contracture syndrome (LCCS) and other lethal arthrogryposes in Finland -: An epidemiological study
Niklas Pakkasjarvi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
Use of prescription medications with a potential for fetal harm among pregnant women
Susan E. Andrade et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)
Safety of medications prescribed before and during early pregnancy in a cohort of 81 975 mothers from the UK General Practice Research Database
Janet R. Hardy et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2006)
Associations between socio-economic factors and the use of prescription medication during pregnancy
Charlotte Olesen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands
MK Bakker et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2006)
Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register
J Morrow et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Post-marketing surveillance system for drugs in pregnancy - 15 years experience of ENTIS
C Schaefer et al.
REPRODUCTIVE TOXICOLOGY (2005)
Prescription drug use in pregnancy
Susan E. Andrade et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Prescription of hazardous drugs during pregnancy
H Malm et al.
DRUG SAFETY (2004)
Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system
E Schirm et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2004)
Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy
FJ Vajda et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2004)
EURAP: An international registry of Antiepileptic drugs and pregnancy
T Tomson et al.
EPILEPSIA (2004)
North American Antiepileptic drug pregnancy registry
LB Holmes et al.
EPILEPSIA (2004)
Drug prescription in pregnancy: analysis of a large statutory sickness fund population
V Egen-Lappe et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Prescription drugs during pregnancy and lactation - a Finnish register-based study
H Malm et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2003)
How do we best detect toxic effects of drugs taken during pregnancy? A EuroMap paper
J Olsen et al.
DRUG SAFETY (2002)
Do pregnant women report use of dispensed medications?
C Olesen et al.
EPIDEMIOLOGY (2001)
Prescription of drugs during pregnancy in France
I Lacroix et al.
LANCET (2000)